South Africa Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613421
  • Pages : 90

South Africa’s Infection Control Market is evaluated at US$99.936 million for the year 2020 and is projected to grow at a CAGR of 4.14% to reach a market size of US$132.712 million by the year 2027.

The market in South Africa is projected to grow fast due to the prevalence of communicable and non-communicable diseases. The substantial utilization of public healthcare facilities is further driving market demand. Furthermore, with the provision of equitable access to tertiary healthcare services in the country, the market for infection control is estimated to strengthen in the forecast period and the upcoming years. Additionally, major market players manufacturing innovative infection control products, including sterilizers, disinfectants, and many more for consumption in the South African region, are contributing to market growth over the next five years. With the growing geriatric population in the country, the focus is shifting towards programs that support the decline of deaths caused by diseases like cardiac disease and diabetes, especially for the population 65 years of age or more. Such initiatives are further poised to provide an opportunity for the market to grow sustainably in the forecast period and the upcoming years.

The impartial access to specialized tertiary healthcare services is propagating the market demand in the forecast period.

The exclusively hospital-based and highly specialized healthcare services require strong coordination from the government owing to the unequal distribution across the country. Hence, several patients are receiving medical care in their neighbouring provinces in case of the non-availability of these services in their home communities. The South African Department of Health (DoH) provides subsidies to 29 tertiary hospitals via the national territory services grant, ensuring that the provincial departments treating patients from other provinces are adequately funded for their activities. The funding covers medical specialists, equipment, advanced medical investigation, and advanced treatments as per the approved service specifications.

On August 12, 2020, the South African government prioritised scaling up IPC; a critical component of quality care and a key component in achieving universal health coverage (UHC). Among other things, the National Department of Health approved the 'National IPC Strategic Framework' and a practical manual for its implementation, which were developed with WHO assistance. The timing was critical for assisting with national control and response to COVID-19.

Healthcare-associated infections are twice as common in low- and middle-income countries as in high-income countries. Strong IPC measures will help save lives among South Africa's 58 million people, particularly in vulnerable populations. They have a direct impact on preventing healthcare-associated infections and the spread of COVID-19, as well as combating current threats posed by epidemics such as Ebola and cholera, other pandemics such as influenza, and antimicrobial resistance (AMR), all of which are becoming increasingly serious public health challenges.

South Africa increased their polio outbreak response on July 7, 2022, by giving multiple vaccination rounds aim to ensure that every child under the age of five is fully immunised against poliovirus in high-risk countries. WHO and partners, including UNICEF, the Bill and Melinda Gates Foundation, the Centers for Disease Control and Prevention, GAVI, the vaccine alliance, and Rotary, are collaborating with national authorities to improve vaccination drive planning, delivery, and monitoring.

The growing geriatric population in the country is surging the market demand in the forecast period.

According to the Mid-year population estimates of statistics South Africa, in 2022, it was indicated that the elderly (60 years or older) population size is increasing; this achieved a percent share of 9.2% of the total population. As per the stats, the estimated geriatric population in the same year was predicted to be 5.59 million. The regional variations of ageing in the country are as follows: almost a quarter of the older people were living in Gauteng, accounting for 7.7% of the total Gauteng population. On the other hand, around 12% of the ageing people were residing in the Eastern Cape. Mpumalanga’s population consists of 7% geriatric, which was considered the lowest among the provinces.

The health programs dedicated to HIV contributed to decreased deaths related to communicable diseases such as HIV and tuberculosis. The focus is now being shifted towards the treatment of non-communicable diseases, which include heart disorders and diabetes, specifically for individuals that are aged 65 years of age or more.

Recent development and expansions

Sonoma Pharmaceuticals, Inc., is a leader in global healthcare that develops and manufactures stabilized hypochlorous acid (HOCl) products based on patented Microcyn® technology. In March 2022, the company launched a catheter and bladder rinse for urinary tract infections, in New Zealand, Australia, and South Africa.

COVID-19 impact on South Africa Infection Control Market

The South African government's underestimation of the severity of COVID-19 resulted in delayed action against the pandemic. Since WHO declared COVID-19 a pandemic, global pandemic preparedness has been vastly improved. To mitigate the impact of COVID-19, South African authorities implemented physical separation, self-isolation, closure of non-essential services, schools, travel restrictions, and recursive national lockdowns.

The South African health system is being harmed by a lack of PPEs, rising mortality rates, mental health issues, substance abuse, and the resurgence of NCDs. International border closures, global demand meltdowns, supply disruptions, and dramatic reductions in human and industrial activity during the lockdown all contribute to socioeconomic problems. The prolonged effects of the lockdown on psychosocial support services resulted in outbursts of uncertainty, acute panic, fear, depression, obsessive behaviours, social unrest, stigmatisation, anxiety, an increase in cases of gender-based violence, and discrimination in the distribution of relief food aid.

To slow the spread of COVID-19, massive testing, contact tracing, isolation, and home quarantine guidelines for asymptomatic cases that promote behavioural change, and a review of food relief policy must be implemented.

South Africa Infection Control Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$99.936 million
 Market Size Value in 2027  US$132.712 million
 Growth Rate  CAGR of 4.14% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Product, And End-User Industry
 Companies Covered 3M, STERIS plc, Becton, Dickinson and Company, Getinge AB, B. Braun Melsungen AG
 Customization Scope  Free report customization with purchase

 

Market Segmentation:

  • By Product
    • Disinfectant
    • Sterilization
      • Low-temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End-User Industry
    • Healthcare
    • Food and Beverage
    • Chemical

1. INTRODUCTION
1.1. Market Overview
1.2. Covid-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY
3.1. Research Highlights

4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.4. Industry Value Chain Analysis

5. SOUTH AFRICAN INFECTION CONTROL MARKET, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low-temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization

6. SOUTH AFRICAN INFECTION CONTROL MARKET, BY END-USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix

8. COMPANIES MENTIONED
8.1. 3M
8.2. STERIS plc
8.3. Becton, Dickinson and Company
8.4. Getinge AB
8.5. B. Braun Melsungen AG

3M

STERIS plc

Becton, Dickinson and Company

Getinge AB

B. Braun Melsungen AG